Cognitive Behavioral Therapy for Insomnia (CBTi) in Patients With Comorbid Somatic Disease and Insomnia
Cognitive Behavioral Therapy for Insomnia (CBTi) in Patients With Somatic Disease
Sponsor: Diakonhjemmet Hospital
Listed as NCT04598672, this observational or N/A phase trial focuses on Chronic Disease and Insomnia and remains completed. Sponsored by Diakonhjemmet Hospital, it has been updated 9 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
May 4, 2026 — Present [daily]
Completed
Status: Active Not Recruiting → Completed · Phase: NA → None
-
Sep 2024 — May 2026 [monthly]
Active Not Recruiting NA
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Aug 2024 [monthly]
Active Not Recruiting NA
-
Mar 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
▶ Show 4 earlier versions
-
Oct 2022 — Mar 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Mar 2021 — Oct 2022 [monthly]
Recruiting NA
-
Jan 2021 — Mar 2021 [monthly]
Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Jan 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
Insomnia is common with co-morbid somatic disease, e.g. rheumatic disease, cancer, heart and lung disease or gastrointestinal disorders. Pain, breathing difficulties and other symptoms of disease can worsen sleep problems and cause insomnia. In turn, insomnia may aggravate pain, fatigue and reduce quality of life in patients with somatic disorders. This project aims to evaluate a course offered to patients with insomnia and somatic disease at Diakonhjemmet Hospital. The course is based on cognitive behavioral therapy, a documented treatment for insomnia.
Contact Information
- Diakonhjemmet Hospital
For direct contact, visit the study record on ClinicalTrials.gov .